Exit valuation of Ohmic Biosciences (YC S23)? | Manifold

Exit valuation of Ohmic Biosciences (YC S23)?

Basic

1

Ṁ30

2100

59%

Less than $10M or bankrupt

14%

$10M - $100M

14%

$100M - $1B

14%

$1B+

When Ohmic Biosciences goes bankrupt, gets acquired, or goes public with an IPO, what will its valuation be?

https://www.ycombinator.com/companies/ohmic-biosciences

Ohmic Biosciences: Genetically engineering plants for disease resistance. | Y Combinator

Genetically engineering plants for disease resistance. Founded in 2021 by Matthew Bedewitz and PJ Steiner, Ohmic Biosciences has 2 employees based in Alameda, CA, USA.

This question is managed and resolved by Manifold.

Get

1,000

and

3.00

Related questions

Exit valuation of MantleBio (YC S23)?

Exit valuation of Healthtech 1 (YC S23)?

Exit valuation of Certainly Health (YC S23)?

Exit valuation of Kobalt Labs (YC S23)?

Exit valuation of Shasta Health (YC S23)?

Exit valuation of Feanix Biotechnologies (YC S23)?

Exit valuation of Obento Health (YC S23)?

Exit valuation of Decoda Health (YC S23)?

Exit valuation of Empirical Health (YC S23)?

Exit valuation of Isocode (YC S23)?

Related questions

Exit valuation of MantleBio (YC S23)?

Exit valuation of Feanix Biotechnologies (YC S23)?

Exit valuation of Healthtech 1 (YC S23)?

Exit valuation of Obento Health (YC S23)?

Exit valuation of Certainly Health (YC S23)?

Exit valuation of Decoda Health (YC S23)?

Exit valuation of Kobalt Labs (YC S23)?

Exit valuation of Empirical Health (YC S23)?

Exit valuation of Shasta Health (YC S23)?

Exit valuation of Isocode (YC S23)?

© Manifold Markets, Inc.•Terms + Mana-only Terms•Privacy•Rules